DXCM · 10-Q · 2026Q3 · Full report

Operating Income and Margins

DEXCOM INC · 2026-10-29 · Importance 79 · Surprise 64 · No source text

Nine-month operating income rose $312.0 million, or approximately 53%, to $900.8 million from $588.8 million in 2025. Third-quarter operating income increased $84.7 million, or 35%, to $327.2 million. Nine-month net income increased $154.7 million to $723.7 million, while third-quarter net income declined 3% to $275.1 million. The third-quarter comparison included a $102.3 million decline in other income, primarily reflecting the absence of an $82.5 million prior-year gain on equity investments and $18.4 million lower interest and dividend income.

Key facts

• Third-quarter 2026 operating income was $327.2 million, up 35% from the same period in 2025. source
• Nine-month 2026 operating income was $900.8 million, compared with $588.8 million in the first nine months of 2025, an increase of $312.0 million. source
• Third-quarter 2026 operating income was $327.2 million, compared with $242.5 million in the third quarter of 2025, an increase of $84.7 million. source
• Third-quarter 2026 other income, net, decreased by $102.3 million, or 93%, compared with the prior-year quarter. source
• Nine-month 2026 net income was $723.7 million, compared with $569.0 million in the first nine months of 2025, an increase of $154.7 million. source
• Third-quarter 2026 net income was $275.1 million, down 3% from the same period in 2025. source
• Third-quarter 2026 net income was $275.1 million, compared with $283.8 million in the third quarter of 2025, a decrease of $8.7 million or 3%. source
• Third-quarter 2026 diluted net income per share was $0.72, compared with $0.70 in the third quarter of 2025, an increase of $0.02. source

Impact estimates